Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...

Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

A study published in July 2025 issue of Journal of Neurology explored how genetic variability in the FCGR2/3 locus, which ...

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.

Guillain-Barré Syndrome (GBS) poses a diagnostic challenge due to its misleading symptoms, the lack of a definitive test, and similarities with other conditions. Early detection is crucial to ...

Doctors and genetic researchers at The University of Manchester have discovered that changes in a gene leads to severe nerve damage in children following a mild bout of infection.

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

Pathogenesis articles from across Nature Portfolio Pathogenesis is the term that is used to describe the origin and development of a disease.